111 related articles for article (PubMed ID: 21762926)
1. Neural reward processing under dopamine agonists: imaging.
Kassubek J; Abler B; Pinkhardt EH
J Neurol Sci; 2011 Nov; 310(1-2):36-9. PubMed ID: 21762926
[TBL] [Abstract][Full Text] [Related]
2. At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists.
Abler B; Hahlbrock R; Unrath A; Grön G; Kassubek J
Brain; 2009 Sep; 132(Pt 9):2396-402. PubMed ID: 19567700
[TBL] [Abstract][Full Text] [Related]
3. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
Bayard S; Cochen De Cock V; Dauvillers Y
Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
[TBL] [Abstract][Full Text] [Related]
4. Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease.
Fenu S; Wardas J; Morelli M
Behav Pharmacol; 2009 Sep; 20(5-6):363-79. PubMed ID: 19724195
[TBL] [Abstract][Full Text] [Related]
5. Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management.
Wu K; Politis M; Piccini P
Postgrad Med J; 2009 Nov; 85(1009):590-6. PubMed ID: 19892894
[TBL] [Abstract][Full Text] [Related]
6. Impulse control disorders and dopaminergic treatments in Parkinson's disease.
Villa C; Pascual-Sedano B; Pagonabarraga J; Kulisevsky J
Rev Neurol (Paris); 2011 Nov; 167(11):827-32. PubMed ID: 21596410
[TBL] [Abstract][Full Text] [Related]
7. Impulsive and compulsive behaviors in Parkinson's disease.
Evans AH; Strafella AP; Weintraub D; Stacy M
Mov Disord; 2009 Aug; 24(11):1561-70. PubMed ID: 19526584
[TBL] [Abstract][Full Text] [Related]
8. Depression and impulse control disorders in Parkinson's disease: two sides of the same coin?
Vriend C; Pattij T; van der Werf YD; Voorn P; Booij J; Rutten S; Berendse HW; van den Heuvel OA
Neurosci Biobehav Rev; 2014 Jan; 38():60-71. PubMed ID: 24239733
[TBL] [Abstract][Full Text] [Related]
9. Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson's disease.
van der Vegt JP; Hulme OJ; Zittel S; Madsen KH; Weiss MM; Buhmann C; Bloem BR; Münchau A; Siebner HR
Brain; 2013 Apr; 136(Pt 4):1192-203. PubMed ID: 23442226
[TBL] [Abstract][Full Text] [Related]
10. Long term follow-up of Parkinson's disease patients with impulse control disorders.
Sohtaoğlu M; Demiray DY; Kenangil G; Ozekmekçi S; Erginöz E
Parkinsonism Relat Disord; 2010 Jun; 16(5):334-7. PubMed ID: 20223696
[TBL] [Abstract][Full Text] [Related]
11. Differential behavioral reinforcement effects of dopamine receptor agonists in the rat with bilateral lesion of the posterior ventral tegmental area.
Ouachikh O; Dieb W; Durif F; Hafidi A
Behav Brain Res; 2013 Sep; 252():24-31. PubMed ID: 23727149
[TBL] [Abstract][Full Text] [Related]
12. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
Blum K; Gold MS
Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
[TBL] [Abstract][Full Text] [Related]
13. Impulse control disorder and piribedil: report of 5 cases.
Tschopp L; Salazar Z; Gomez Botello MT; Roca CU; Micheli F
Clin Neuropharmacol; 2010; 33(1):11-3. PubMed ID: 19959959
[TBL] [Abstract][Full Text] [Related]
14. Dopamine-dependent architecture of cortico-subcortical network connectivity.
Cole DM; Oei NY; Soeter RP; Both S; van Gerven JM; Rombouts SA; Beckmann CF
Cereb Cortex; 2013 Jul; 23(7):1509-16. PubMed ID: 22645252
[TBL] [Abstract][Full Text] [Related]
15. Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management.
Ceravolo R; Frosini D; Rossi C; Bonuccelli U
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S111-5. PubMed ID: 20123548
[TBL] [Abstract][Full Text] [Related]
16. Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
Pourcher E; Rémillard S; Cohen H
J Neurol Sci; 2010 Mar; 290(1-2):52-6. PubMed ID: 19969309
[TBL] [Abstract][Full Text] [Related]
17. Dopamine, reward, and frontostriatal circuitry in impulse control disorders in Parkinson's disease: insights from functional imaging.
Ray N; Strafella AP
Clin EEG Neurosci; 2010 Apr; 41(2):87-93. PubMed ID: 20521491
[TBL] [Abstract][Full Text] [Related]
18. Intertemporal choice in Parkinson's disease.
Milenkova M; Mohammadi B; Kollewe K; Schrader C; Fellbrich A; Wittfoth M; Dengler R; Münte TF
Mov Disord; 2011 Sep; 26(11):2004-10. PubMed ID: 21567457
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
[TBL] [Abstract][Full Text] [Related]
20. Medication-related impulse control and repetitive behaviors in Parkinson's disease.
Voon V; Potenza MN; Thomsen T
Curr Opin Neurol; 2007 Aug; 20(4):484-92. PubMed ID: 17620886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
